William Long, MD Ohio AAP Asthma CQN 3 CME Disclosure Statement William Long, MD I have no relevant financial relationships with the manufacturer(s) of any commercial product(s) and/or provider of commercial services discussed in the CME activity. I do not intend to discuss unapproved or investigative use of a commercial product/device in my presentation. Sugges'ons/Thoughts   Incorporate daily “huddles” (counts for PCMH certiﬁcation)   Protocol for follow up of ED/UC visits and hospitalizations (also PCMH)   Protocol for follow up of missed appointments (again, PCMH)   Develop a Spirometry strategy and goals to increase the number of eligiblepatients receiving spirometry in your oﬃce AAP CQN3 90 Day Goals July to September GOAL MEASURE CHALLENGES 100% of practices participate in monthly calls Participate in an Organized Quality Improvement Eﬀort Busy practices and busy time of year 100% of practices enter practice level data Measure Performance and Share Data Registry speed 90% of practices achieve optimal Measure Performance and Share care Data n/a 80% of practices complete a PDSA on population management (ﬂu vaccine, controller meds, etc) to asthma care LS3 is on September 20 – practices will have a draft of the PDSA cycle. Implementation by September 30 may be varied. Sustainable & Accountable Leadership Focused on Health Outcomes Beyond 90 Day Goals   Update asthma population/billing query December 13-‐ January 14   75% of patients uploaded have encounter form level data by the end of the collaborative Action Period Checklist In Your Packet CME Evalua'ons You will receive an email at the close of this session with a link to your CME evaluation form. http://www.surveymonkey.com/s/OhioCQN3LS3 Upon completion of the survey, you will receive your certiﬁcate for your records. Thank you!!!!!! Upcoming Dates September Data - September 30 at Midnight (October 5 grace period) Learning Sessions - Learning Session 4 on March 27, 2014 (webinar) 2-4 pm